The Impact of Repetitive Oocyte Retrieval on the Ovarian Reserve: a Retrospective Cohort Study

Overview

Journal Arch Gynecol Obstet

Specialty Gynecology & Obstetrics

Date 2019 Feb 22

PMID 30790103

Citations 2

Authors

Julian Marschalek

Johannes Ott

Matthias Aitzetmueller

Daniel Mayrhofer

Andrea Weghofer

Kazem Nouri

Katharina Walch

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate a possible influence of repetitive micro-traumata on the ovaries in the course of oocyte retrieval during IVF/ICSI treatment on serum anti-Müllerian hormone (AMH) levels.

Methods: The study included retrospectively collected data from women who underwent three or more consecutive IVF/ICSI treatments between 2007 and 2017. The primary endpoint of the study was to evaluate changes in serum AMH levels on cycle days 1-3 during the course of repetitive IVF/ICSI treatments.

Results: A total of 125 patients were included in this study. Median AMH levels before the first, second and third IVF/ICSI cycles were 3.8 ng/mL (IQR 1.8-7.1), 3.3 ng/mL (IQR 1.8-6.1) and 3.0 ng/mL (IQR 1.6-5.3), respectively (p = n.s.). In patients who underwent IVF/ICSI due to polycystic ovary syndrome (PCOS), we found a significant decrease in AMH serum levels between the first [AMH 9.7 ng/mL (IQR 7.4-14.4)] and the third [AMH 5.3 ng/mL (IQR 3.3-10.4)] IVF/ICSI cycles (p = 0.026). When performing a generalized linear model, we found PCOS to be an independent predictor for serum AMH decrease during the course of three oocyte retrievals (p < 0.001).

Conclusions: When comparing the indications for IVF/ICSI, we observed a significant decrease in AMH serum levels after repetitive oocyte retrievals only in women with PCOS, while the decrease in AMH was not significant in patients with tubal factor, endometriosis, male factor and unexplained infertility. This finding leads us to hypothesize that repetitive micro-traumata on the ovarian cortex might diminish/normalize functional ovarian reserve in women with PCOS. Further prospective studies are highly warranted to allow firm conclusions.

Citing Articles

Population Dynamics, Plasma Cytokines and Platelet Centrifugation: Technical and Sociodemographic Aspects of 'Ovarian Rejuvenation'.

Scott Sills E, Tan S Clin Pract. 2023; 13(2):435-441.

PMID: 36961064 PMC: 10037579. DOI: 10.3390/clinpract13020039.

Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40.

Scott Sills E, Rickers N, Wood S Int J Reprod Biomed. 2021; 18(12):1081-1086.

PMID: 33426419 PMC: 7778756. DOI: 10.18502/ijrm.v18i12.8030.

References

Abu Hashim H, Foda O, El Rakhawy M . Unilateral or bilateral laparoscopic ovarian drilling in polycystic ovary syndrome: a meta-analysis of randomized trials. Arch Gynecol Obstet. 2018; 297(4):859-870. DOI: 10.1007/s00404-018-4680-1. View

Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M . Anti-Müllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011; 96(5):1246-51.e1. DOI: 10.1016/j.fertnstert.2011.08.015. View

Farquhar C, Brown J, Marjoribanks J . Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2012; (6):CD001122. DOI: 10.1002/14651858.CD001122.pub4. View

Rezk M, Sayyed T, Saleh S . Impact of unilateral versus bilateral laparoscopic ovarian drilling on ovarian reserve and pregnancy rate: a randomized clinical trial. Gynecol Endocrinol. 2015; 32(5):399-402. DOI: 10.3109/09513590.2015.1124262. View

Iwase A, Nakamura T, Osuka S, Takikawa S, Goto M, Kikkawa F . Anti-Müllerian hormone as a marker of ovarian reserve: What have we learned, and what should we know?. Reprod Med Biol. 2017; 15(3):127-136. PMC: 5715856. DOI: 10.1007/s12522-015-0227-3. View

Weenen C, Laven J, von Bergh A, Cranfield M, Groome N, Visser J . Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004; 10(2):77-83. DOI: 10.1093/molehr/gah015. View

Hirokawa W, Iwase A, Goto M, Takikawa S, Nagatomo Y, Nakahara T . The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum Reprod. 2011; 26(4):904-10. DOI: 10.1093/humrep/der006. View

Farzadi L, Nouri M, Ghojazadeh M, Mohiti M, Aghadavod E . Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome. Bioimpacts. 2013; 2(3):167-70. PMC: 3648929. DOI: 10.5681/bi.2012.018. View

Agdi M, Zarei A, Al-Sannan B, Tulandi T, Tan S . Effects of ovarian puncture for in vitro maturation on subsequent in vitro fertilization cycle in women with polycystic ovaries. Fertil Steril. 2009; 94(1):381-3. DOI: 10.1016/j.fertnstert.2009.09.033. View

10.

Amer S, Shamy T, James C, Yosef A, Mohamed A . The impact of laparoscopic ovarian drilling on AMH and ovarian reserve: a meta-analysis. Reproduction. 2017; 154(1):R13-R21. DOI: 10.1530/REP-17-0063. View

11.

Kitajima M, Khan K, Hiraki K, Inoue T, Fujishita A, Masuzaki H . Changes in serum anti-Müllerian hormone levels may predict damage to residual normal ovarian tissue after laparoscopic surgery for women with ovarian endometrioma. Fertil Steril. 2011; 95(8):2589-91.e1. DOI: 10.1016/j.fertnstert.2011.01.036. View

12.

Bentzen J, Forman J, Johannsen T, Pinborg A, Larsen E, Nyboe Andersen A . Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J Clin Endocrinol Metab. 2013; 98(4):1602-11. DOI: 10.1210/jc.2012-1829. View

13.

Calhaz-Jorge C, De Geyter C, Kupka M, de Mouzon J, Erb K, Mocanu E . Assisted reproductive technology in Europe, 2013: results generated from European registers by ESHRE. Hum Reprod. 2017; 32(10):1957-1973. DOI: 10.1093/humrep/dex264. View

14.

Koninger A, Koch L, Enekwe A, Birdir C, Kasimir-Bauer S, Kimmig R . Change of anti-Mullerian-hormone levels during follicular phase in PCOS patients. Gynecol Endocrinol. 2014; 31(1):26-30. DOI: 10.3109/09513590.2014.959436. View

15.

Raffi F, Metwally M, Amer S . The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012; 97(9):3146-54. DOI: 10.1210/jc.2012-1558. View

16.

Fanchin R, Schonauer L, Righini C, Guibourdenche J, Frydman R, Taieb J . Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod. 2003; 18(2):323-7. DOI: 10.1093/humrep/deg042. View

17.

Andersen C, Schmidt K, Kristensen S, Rosendahl M, Grete Byskov A, Ernst E . Concentrations of AMH and inhibin-B in relation to follicular diameter in normal human small antral follicles. Hum Reprod. 2010; 25(5):1282-7. DOI: 10.1093/humrep/deq019. View

18.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

19.

Anderson R, Nelson S, Wallace W . Measuring anti-Müllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?. Maturitas. 2011; 71(1):28-33. DOI: 10.1016/j.maturitas.2011.11.008. View

20.

Hyldgaard J, Bor P, Ingerslev H, Torring N . Comparison of two different methods for measuring anti-mullerian hormone in a clinical series. Reprod Biol Endocrinol. 2015; 13:107. PMC: 4580367. DOI: 10.1186/s12958-015-0101-5. View